ARMA for Postoperative GERD After Sleeve Gastrectomy

Anti-reflux Mucosal Ablation (ARMA) for the Treatment of Postoperative Gastroesophageal Reflux After Sleeve Gastrectomy - A Pilot Study

This study is a pilot trial designed to evaluate the safety and efficacy of endoscopic anti-reflux ablation in postoperative gastroesophageal reflux after sleeve gastrectomy

Inclusion Criteria:

• Patients with reflux symptoms after sleeve gastrectomy and are dependent on or refractory to PPI treatment
• Pathological esophageal acid exposure, defined by DeMeester score >14.7 or acid exposure time (AET) >4.2% on pH study

Exclusion Criteria:

• Primary esophageal motility disorders
• Sliding hiatal hernia >3cm
• Narrow gastric sleeve that precludes retroflexion of scope
• Gastric sleeve stricture
• Malignancy
• Pregnancy
• Patients not fit for general anesthesia
• Other cases deemed by the examining physician as unsuitable for safe treatment
• Refusal to participate